`
`
`
`Filed on behalf of Valencell, Inc.
`By: Daniel F. Olejko (dolejko@bosfirm.com)
`
`Jeffrey R. Bragalone (jbragalone@bosfirm.com)
`
`Bragalone Olejko Saad PC
`
`2200 Ross Ave.
`
`Suite 4600 – West
`
`Dallas, TX 75201
`
`Tel: 214.785.6670
`
`Fax: 214.786.6680
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`FITBIT, INC.,1
`Petitioner,
`
`v.
`
`VALENCELL, INC.,
`Patent Owner.
`
`
`Case IPR2017-003192
`U.S. Patent No. 8,923,941
`
`
`PATENT OWNER’S REQUEST FOR DIRECTOR REVIEW
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`
`
`1 Petitioner Apple Inc. (“Apple”) is no longer a party in this proceeding.
`
`2 Case IPR2017-01555 has been joined with this proceeding.
`
`
`
`
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`TABLE OF CONTENTS
`
`INTRODUCTION ............................................................................................1
`
`FACTUAL BACKGROUND ...........................................................................2
`
`A.
`
`B.
`
`III. ARGUMENTS AND AUTHORITIES .............................................................8
`
`A.
`
`Overview of the Challenged Claims .....................................................2
`
`Summary of the Proceedings ................................................................3
`
`The Board Misapprehended or Overlooked the Fact That Fitbit’s
`Arguments on Remand Were Not Made in the Petition. .......................8
`
`I.
`
`II.
`
`
`B.
`
`The Board Misapprehended or Overlooked the Fact That Fitbit’s New
`Arguments Concerning Craw Contradict the Arguments in the Petition
`and Petitioner’s Own Expert’s Testimony. .......................................... 11
`
`The Board Overlooked or Misapprehended the Teachings of Craw. ..12
`
`
`
`
`C.
`
`IV. CONCLUSION ..............................................................................................15
`
`
`
`i
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`TABLE OF AUTHORITIES
`
`Cases
`
`adidas AG v. Nike, Inc.,
` IPR2016-00922, 2018 WL 4056113 (P.T.A.B. Aug. 24, 2018) .............................8
`
`Apple Inc. v. INVT SPE LLC,
` IPR2018-01472, 2020 WL 865280 (P.T.A.B. Feb. 21, 2020) ..............................12
`
`Atl. Thermoplastics Co. v. Faytex Corp.,
` 5 F.3d 1477 (Fed. Cir. 1993) ................................................................................ 11
`
`Cisco Sys., Inc. v. Oyster Optics, LLC,
` IPR2017-01719, 2019 WL 328734 (P.T.A.B. Jan. 24, 2019) .................................8
`
`Fitbit, Inc. v. Valencell, Inc.,
` 964 F.3d 1112 (Fed. Cir. 2020) ........................................................................ 4, 11
`
`InfoBionic, Inc. v. Braemar Mfg., LLC,
` IPR2017-00796, 2018 WL 3618694 (P.T.A.B. July 27, 2018) ............................12
`
`SAS Inst., Inc. v. Iancu,
` 138 S. Ct. 1348 (2018) ...........................................................................................8
`
`United States v. Arthrex, Inc.,
` 141 S. Ct. 1970 (2021) ...........................................................................................1
`
`Valencell, Inc. v. Fitbit, Inc.,
` No. 21-2041 (Fed. Cir. Nov. 10, 2021) ..................................................................1
`
`Rules
`
`37 C.F.R. § 42.104(b)(4) ............................................................................................8
`
`37 C.F.R. § 42.71(d) ..................................................................................................1
`
`
`ii
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`I.
`INTRODUCTION
`Pursuant to the Federal Circuit’s Order granting limited remand in light of
`
`United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021),3 and 37 C.F.R. § 42.71(d),
`
`Patent Owner Valencell, Inc. (“Valencell”) submits this Request for Director Review
`
`of the Board’s Final Written Decision on Remand, which found that claims 3–5 (the
`
`“challenged claims”) of U.S. Patent No. 8,923,941 (the “’941 patent”) are
`
`unpatentable as obvious over Luo and Craw, alone or in combination with Wolf. See
`
`Paper 73 at 18–34, 46–47. Review by the Director is warranted because the Board’s
`
`Final Written Decision on Remand is premised on new arguments about the prior art
`
`that were not made in the Petition and that conflict with the arguments actually made
`
`in the Petition and the testimony of Petitioner’s own expert witness. Further, the
`
`Board’s findings also rest on fundamental misunderstandings of the disclosures in
`
`the prior art. Because Drew Hirshfeld has not been appointed by the President and
`
`confirmed by the Senate as the Director of the Patent and Trademark Office (“PTO”)
`
`
`3 Following Valencell’s Notice of Appeal, the Supreme Court issued its decision in
`
`Arthrex. Valencell thereafter filed a motion for stay and limited remand with the
`
`Federal Circuit, which the Court granted on November 10, 2021. See Valencell, Inc.
`
`v. Fitbit, Inc., No. 21-2041 (Fed. Cir. Nov. 10, 2021), Doc. No. 26. This request is
`
`timely as it comes within 30 days of the Federal Circuit’s order. See id. at 2.
`
`1
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`as required by Arthrex, Valencell respectfully requests that the PTO defer
`
`consideration of this Request until a new Director is confirmed.
`
`II.
`
`FACTUAL BACKGROUND
`A. Overview of the Challenged Claims
`The ’941 patent, entitled “Methods and Apparatus for Generating Data Output
`
`Containing Physiological and Motion-related Information,” discloses wearable
`
`monitors used to measure multiple types of physiological and motion-related
`
`information about a person. Ex. 1001, Abstract. One type of sensor used by the
`
`monitors is a photoplethysmography (“PPG”) sensor, which can be used to measure
`
`a person’s heart rate. Id. at 4:3–5. Another type of sensor used by the monitors is a
`
`motion sensor for sensing physical activity. Id. at 30:41.
`
`Of particular relevance, the ’941 patent discloses generating a “serial data
`
`output” that “is parsed out such that an application-specific interface can utilize the
`
`physiological information and motion-related information for an application” to
`
`assess the person’s fitness or health. Id., Abstract (emphasis added). Figure 17
`
`illustrates the generation of such a serial data string 604 from sensor input, and the
`
`serial data string 700 is also illustrated in Figure 18, where the different types of
`
`information are parsed out for use by a particular application. Id. at 25:65–26:33. In
`
`discussing Figures 17 and 18, the patent further explains that:
`
`The multiplexed data outputs 604 may be a serial data string of activity
`and physiological information 700 (FIG. 18) parsed out specifically
`
`2
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`such that an application-specific interface (API) can utilize the data as
`required for a particular application. The applications may use this
`data to generate high-level assessments, such as overall fitness or
`overall health.
`
`Id. at 26:15–21 (emphasis added). The challenged claims require that “the serial data
`
`output is parsed out such that an application-specific interface (API) can utilize the
`
`physiological information and motion-related information for an application.” Id.
`
`at 30:62–65 (emphasis added).
`
`B. Summary of the Proceedings
`The grounds of unpatentability in the Petition were premised on Petitioner’s
`
`proposed construction of a key term in the challenged claims: “application-specific
`
`interface (API)” in claim 3. Petitioner argued that the word “specific” in
`
`“application-specific interface (API)” was a typographical error and that the patentee
`
`actually meant to claim the use of “application programming interface” or “APIs,”
`
`which “are [] characterized by their broad applicability to different applications—
`
`and not ‘application specific’ as such.” Paper 2 at 14 (emphasis added). Petitioner
`
`asserted that “Craw teaches that a data dictionary used with data classes acts as an
`
`API for managing, extracting, and displaying information from information
`
`streams.” Id. at 27 (citing Ex. 1056 ¶ 256, Ex. 1003 ¶ 92) (emphasis added). As
`
`Petitioner’s expert explained, Craw’s “dictionary provides interfaces to access all
`
`types of definitions abstractly and anonymously, to provide the developer with a
`
`3
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`generic mechanism to handle definitions that might come from connected devices.”
`
`Ex. 1003 ¶ 75 (emphasis added). Further, “Craw teaches that string tables provide a
`
`generic interface that are used by any software project to manage and access strings
`
`based on symbolic links.” Id. ¶ 76 (emphasis added). Craw’s “data dictionary used
`
`with DMOIB [Dynamic Medical Object Information Base] and string table classes
`
`may act as interfaces for managing, extracting, and displaying information from
`
`binary information streams.” Id. ¶ 92. Thus, Petitioner’s expert concluded that “a
`
`person of ordinary skill in the art would have recognized that the data dictionary acts
`
`as an API.” Id. (emphasis added).
`
`In its initial Final Written Decision, the Board rejected Petitioner’s proposed
`
`constructions of “application-specific interface” in claim 3 and concluded that,
`
`“[b]ecause Petitioner’s assertions challenging claim 3 are based on the rejected
`
`construction of [application-specific interface], and the evidentiary support relied
`
`upon is predicated on the same,” Petitioner had failed to meet its burden of proof.
`
`Paper 43 at 17–18. On appeal, the Federal Circuit affirmed the Board’s construction
`
`of “application-specific interface,” agreeing that “an ‘application specific interface
`
`(API)’ is directed to a ‘particular application,’ rather than broadly to different
`
`applications.” Fitbit, Inc. v. Valencell, Inc., 964 F.3d 1112, 1117 (Fed. Cir. 2020)
`
`(emphasis in original). Notwithstanding, the Federal Circuit noted in dicta that “[t]he
`
`Board’s narrowing construction may have no significance, where, as here, the
`
`4
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`claimed ‘application-specific interface’ performs the same function as an application
`
`programming interface, i.e., ‘enabl[ing] a particular application to utilize data
`
`obtained from hardware.’” Id. Further, the Federal Circuit held that “[t]he Board
`
`erred in holding that since it did not adopt Fitbit’s claim construction, that decided
`
`the question of patentability.” Id. at 1118. It vacated the Board’s decision with respect
`
`to claims 3–5 and “remanded for determination of the merits of patentability on the
`
`grounds presented in the petition.” Id. at 1120 (emphasis added).
`
`On remand, the Board ordered the parties to submit supplemental briefing.
`
`Paper 57 at 10–11. In its brief on remand, Fitbit argued for the first time that “Craw’s
`
`‘interfaces’ each qualify as an ‘application specific interface (API)’ under the
`
`Board’s narrowing construction,” that the claimed “application-specific interface”
`
`performs the same function as an API, and that “Craw’s interfaces are also used by
`
`specific applications.” Paper 60 at 6. As an example, Fitbit asserted that “Craw
`
`teaches that a health-monitoring application, such as the blood pressure application
`
`of Figure 9A, uses the disclosed interfaces in order to display extracted health data.”
`
`Id. (citing Ex. 1056 ¶¶ 203, 208). In addition, Fitbit made a new argument that “Craw
`
`discloses
`
`tailoring
`
`the ‘application-specific
`
`interface (API)’
`
`to a specific
`
`application.” Id. at 7. “For example, Craw discloses using ‘a decipherable dictionary
`
`and an interpreter’ in order to ‘extract information and act on it,’ and further teaches
`
`that ‘[a]cting on the received information may depend on the goal of the
`
`5
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`application.” Id. (citing Ex. 1056 ¶ 48) (emphasis in original). Thus, Fitbit asserted
`
`that “Craw … recognizes that ‘medical devices may include one or more types of
`
`software, and the medical devices and software may be configured to operate upon
`
`a particular subset of physiological data.” Id. (citing Ex. 1056 ¶ 4) (emphasis in
`
`original). Fitbit concluded that “not only are Craw’s ‘interfaces’ used by ‘a particular
`
`application,’ they can be specifically tailored to each ‘particular application.’” Id.
`
`Following an oral hearing, the Board issued its Final Written Decision on
`
`Remand. See Paper 73. The Board found “that Craw’s ‘interfaces,’ like the recited
`
`‘application-specific interface,’ enable a particular application to utilize data
`
`obtained from hardware.” Id. at 23. It based this finding on the background section
`
`of Craw, which stated that “[t]he following description describes use of a system
`
`from
`
`interoperability of medical devices on a network and particularly
`
`measurements of non-invasive blood pressure (‘NIBP’), but it is understood that this
`
`example is merely illustrative and other uses and fields of use are contemplated” and
`
`that the “MOIB [Medical Object Information Base] may include a dictionary and
`
`classification mechanism used to model information sets that represent human
`
`physiology or other information models.” Id. (citing Ex. 1056 ¶¶ 51–52) (emphasis
`
`in original). However, the Petition did not rely on this portion of Craw to establish
`
`the disclosure of the claimed “application-specific interface.” See Paper 2 at 27.
`
`The Board highlighted Fitbit’s new arguments that “Craw’s teach[es] that its
`
`6
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`dictionary-based interfaces ‘[a]ct[] on the received information’ in a way that
`
`‘depend[s] on the goal of the application’” and that “Craw thus expressly teaches
`
`interfaces directed to a ‘particular application,’ regardless of whether those
`
`interfaces are also ‘interoperable’ with other applications.” Paper 73 at 24
`
`(emphasis in original). It further cited Craw’s disclosure that “the data dictionary is
`
`derived from a device data sheet, and … the data dictionary comprises one or more
`
`data definitions specific to the network device and a global unique identifier for the
`
`network devices,” that it “extract[s] information from the data according to the data
`
`dictionary,” and that the “dictionaries may include information specific to the data.”
`
`Id. (citing Ex. 1056 ¶¶ 13, 18) (emphasis in original). Notwithstanding the fact that
`
`the Petition did not rely on paragraphs 13 or 18 of Craw as disclosing the claimed
`
`“application-specific interface,” the Board concluded that “Craw makes clear that
`
`the data dictionary interfaces are tailored to be specific to the device or the device
`
`and the measured data.” Id.
`
`Despite Petitioner’s expert testimony that Craw’s data dictionary and data
`
`classes are generic and provide a generic interface used in any software project, the
`
`Board found that “Craw teaches that a health-monitoring application, such as the
`
`blood pressure application, uses the disclosed interfaces, i.e., data dictionaries, in
`
`order to display extracted health data,” that “Craw’s interfaces ‘enabl[e] a particular
`
`application to utilize data obtained from hardware,’ the same function achieved by
`
`7
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`the received ‘application-specific interfaces,’” and “that is all that is required under
`
`[the Board’s] construction of ‘application-specific interface (API)’ and the Federal
`
`Circuit’s guidance.” Id. at 25–26 (citing Ex. 1056 ¶¶ 51–52, 203, 208, Fig. 9A). But
`
`the Petition did not rely on paragraphs 51–52, 208, or Fig. 9A as disclosing the
`
`claimed “application-specific interface.” See Paper 2 at 27.
`
`III. ARGUMENTS AND AUTHORITIES
`A. The Board Misapprehended or Overlooked the Fact That Fitbit’s
`Arguments on Remand Were Not Made in the Petition.
`A remand “does not change [the Board’s] focus on the Petition as Petitioner’s
`
`case-in-chief ….” adidas AG v. Nike, Inc., IPR2016-00922, 2018 WL 4056113, at *3
`
`(P.T.A.B. Aug. 24, 2018) (emphasis added). The “petitioner’s contentions [in the
`
`petition] … define the scope of the litigation all the way from institution through to
`
`conclusion.” SAS Inst., Inc. v. Iancu, 138 S. Ct. 1348, 1355 (2018). The Petition must
`
`identify “[h]ow the construed claim is unpatentable” and “specify where each
`
`element of the claim is found in the prior art patents or printed publications relied
`
`upon.” 37 C.F.R. § 42.104(b)(4).
`
`A petitioner cannot use later briefing as “an opportunity to start anew, to fill
`
`in gaps or to remedy omissions in a petition.” Cisco Sys., Inc. v. Oyster Optics, LLC,
`
`IPR2017-01719, 2019 WL 328734, at *10 (P.T.A.B. Jan. 24, 2019). Yet that is
`
`exactly what Fitbit attempted to do. Faced with the reality that the Petition did not
`
`demonstrate that claims 3–5 are obvious (as the Board had already found), Fitbit
`
`8
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`sought to fill in the gaps and remedy omissions in the Petition by relying on new
`
`disclosures from Craw and making new arguments that contradict the arguments
`
`made in the Petition and Petitioner’s expert testimony. In the Petition, Petitioner
`
`argued only that “Craw teaches that a data dictionary used with data classes acts as
`
`an API for managing, extracting, and displaying information from information
`
`streams.” Paper 2 at 27. Other than the data dictionary from paragraph 256 of Craw,
`
`the Petitioner did not identify any other disclosure in Craw that allegedly teaches or
`
`discloses the claimed “application-specific interface,” much less the claimed
`
`“application-specific interface” as construed by the Board.
`
`Indeed, when Petitioner sought rehearing of the Board’s denial of institution
`
`on claims 3–5, it attempted to argue, as Fitbit did on remand, that Craw discloses the
`
`claimed application-specific interface even under the Board’s construction of the
`
`term. See Paper 13 at 2–3. But the Board rejected Petitioner’s argument, finding that
`
`“the record lacks sufficient evidence to show that there is a reasonable likelihood
`
`that a challenged claim could be found unpatentable by applying the teachings of
`
`those references to a different construction of the term.” Paper 15 at 6. Importantly,
`
`the Board recognized that it “evaluate[s] the arguments and evidence as presented
`
`by the Petitioner in its Petition, including arguments presented for alternative
`
`constructions, if any.” Id. (emphasis modified). Further, the Board found that
`
`“Petitioner did not argue for an alternative construction of the disputed term or for
`
`9
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`the application of the teachings of Lou and Craw to such an alternative
`
`construction.” Id. (emphasis added). Thus, the Board concluded that it could not
`
`“have overlooked or misapprehended an argument that the Petitioner did not
`
`make.” Id. at 6–7 (emphasis added). The Board also rejected Petitioner’s argument
`
`that “claim 3 only requires that the ‘application-specific interface (API)’ ‘can utilize
`
`a particular application’” because it relied on a misinterpretation of the specification,
`
`and because Petitioner did not rely on that language in support of its claim
`
`construction arguments. Id. at 7 n.6.
`
`Fitbit’s argument on remand was nothing more than a recycled version of
`
`Petitioner’s petition for rehearing and should have been rejected by the Board for the
`
`same reasons. Compare Paper 13 at 2–3 (arguing that Craw discloses “[a]cting on
`
`the received information may depend on the goal of the application,” that, “when
`
`implemented, the data dictionary is directed to a particular application,” and that “the
`
`data dictionary’s use is tailored to the specific application that it is intended to
`
`complement”), with Paper 60 at 6–7 (arguing that “Craw’s interfaces are also used
`
`by specific applications,” that “[a]cting on the received information may depend on
`
`the goal of the application,” and that Craw’s interfaces “can be specifically tailored
`
`to each ‘particular application.’”) (emphasis modified). While the Federal Circuit
`
`stated that the Board’s narrowing construction “may have no significance, where, as
`
`here, the claimed ‘application-specific interface’ performs the same function as an
`
`10
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`application programming interface, i.e., ‘enabl[ing] a particular application to utilize
`
`data obtained from hardware,’” Fitbit, 964 F.3d at 1117 (emphasis added), Petitioner
`
`never made that argument in the Petition either. The Federal Circuit’s observation is,
`
`at best, dicta, and cannot be construed as a finding of fact. See Atl. Thermoplastics
`
`Co. v. Faytex Corp., 5 F.3d 1477, 1479 (Fed. Cir. 1993) (“Fact-finding by the
`
`appellate court is simply not permitted.”). Moreover, the Federal Circuit’s statement
`
`that “[o]n remand the Board may consider this aspect” did not grant Fitbit an
`
`unfettered license to expand the scope of the Petition. See id.
`
`B. The Board Misapprehended or Overlooked the Fact That Fitbit’s
`New Arguments Concerning Craw Contradict the Arguments in
`the Petition and Petitioner’s Own Expert’s Testimony.
`Not only did Petitioner not make the arguments made by Fitbit on remand in
`
`the Petition, Fitbit’s argument on remand actually conflicts with the arguments
`
`presented in the Petition as well as Petitioner’s expert testimony.
`
`Petitioner asserted that Craw’s “data dictionary used with data classes acts as
`
`an API.” Paper 2 at 27. Petitioner further contended that “APIs are thus
`
`characterized by their broad applicability to different applications—and not
`
`‘application specific’ as such.” Id. at 14 (emphasis added). Petitioner’s expert
`
`explained that Craw’s “dictionary provides interfaces to access all types of
`
`definitions abstractly and anonymously, to provide the developer with a generic
`
`mechanism to handle definitions that might come from connected devices.”
`
`11
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`Ex. 1003 ¶ 75 (emphasis added). Further, Petitioner’s expert asserted that “Craw
`
`teaches that string tables provide a generic interface that are used by any software
`
`project to manage and access strings based on symbolic links.” Id. ¶ 76 (emphasis
`
`added). This is the exact opposite of the claimed “application-specific interface.”
`
`Indeed, the Board recognized that Lee’s API, a Bluetooth® wireless connection, was
`
`not an application-specific interface because it was “designed for general
`
`applicability across applications.” Paper 73 at 44 (emphasis in original).
`
`Fitbit’s new argument on remand that Craw’s interfaces “can be specifically
`
`tailored to each ‘particular application’” depending on the “goal of the application”
`
`(Paper 60 at 7) contradicts the arguments made in the Petition and its own expert
`
`testimony. Accordingly, it should have been rejected by the Board. See Apple Inc. v.
`
`INVT SPE LLC, IPR2018-01472, 2020 WL 865280, at *11 (P.T.A.B. Feb. 21, 2020)
`
`(rejecting a party’s argument that contradicted its own expert’s testimony);
`
`InfoBionic, Inc. v. Braemar Mfg., LLC, IPR2017-00796, 2018 WL 3618694, at *13
`
`(P.T.A.B. July 27, 2018) (same).
`
`C. The Board Overlooked or Misapprehended the Teachings of Craw.
`In finding that Craw discloses the claimed “application-specific interface,” the
`
`Board relied on Craw’s disclosure that its system is used “for interoperability of
`
`medical devices on a network and particularly measurements of non-invasive blood
`
`pressure.” Paper 73 at 23 (emphasis omitted). But the measurement of non-invasive
`
`12
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`blood pressure is not a “particular application” within the meaning of the
`
`’941 patent. Instead, it is an example of an assessment performed by an application.
`
`Ex. 1001 at 26:15–33 (“The applications may use this data to generate high-level
`
`assessments, such as overall fitness or overall health. Furthermore, the individual
`
`data elements of the data string can be used to facilitate better assessments of other
`
`individual data elements of the data string…. In another example, the filtered PPG
`
`signal may be run through an integration circuit to estimate blood volume over each
`
`blood pulse. This information may then be used to assess blood pressure and blood
`
`oxygen levels more accurately than a direct measurement of blood pressure or blood
`
`oxygen levels.”). Indeed, Craw makes clear that blood pressure measurement is an
`
`example of a “use[]” or “field[] of use” of the system — not an “application.”
`
`Ex. 1056 ¶ 51 (emphasis added).
`
`The Board also relied on Craw’s disclosure that “[a]cting on the received
`
`information may depend on the goal of the application.” Paper 73 at 23–24. But that
`
`disclosure does not concern Craw’s data dictionary or data classes (i.e., the alleged
`
`“application-specific
`
`interface”). It references
`
`the functionality of Craw’s
`
`“interpreter,” which Petitioner did not rely upon for the disclosure of the claimed
`
`“application-specific interface” in the Petition. Compare Paper 2 at 27 (arguing that
`
`Craw’s data dictionary and data classes disclose an API), with Ex. 1056 ¶ 48 (“The
`
`interpreter may use the dictionary to extract information and act on it. Acting on the
`
`13
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`received information may depend on the goal of the information.”) (emphasis
`
`added); see also Paper 71 at 20:7–15 (“[T]hey misstated when they said that the
`
`dictionary actually extracts this information. Instead, it’s the interpreter that is
`
`referred to as doing that. The Petitioner cannot identify only the data dictionary as
`
`being the generic application programming interface, and then come back for the
`
`first time on remand, and say, ‘Oh, it’s the interpreter,’ …. The interpreter is not the
`
`data dictionary.”).
`
`In addition, the Board relied on Craw’s disclosure that “the data dictionary is
`
`derived from a device data sheet” and “comprises one or more data definitions
`
`specific to the network device and a global unique identifier for the network device”
`
`and that the system “extract[s] information from the data according to the data
`
`dictionary.” Paper 73 at 24 (emphasis omitted). But this disclosure makes clear that
`
`the data dictionary is based on “the network device” that is sending the data — not
`
`an application on the device that is receiving the data. See Ex. 1056 ¶ 13 (“receiving
`
`data from the network device”) (emphasis added); see also id. ¶ 49 (noting that the
`
`data dictionary is modeled after a device data sheet, which can be deciphered by
`
`other machines). This disclosure does not suggest that the data dictionary is tailored
`
`to be specific to other devices.
`
`Finally, the Board found that because Craw discloses that “a health-
`
`monitoring application, such as the blood pressure application, uses the disclosed
`
`14
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`interfaces, i.e., data dictionaries, in order to display health data,” the interfaces
`
`perform the same function as the claimed “application-specific interface.” Paper 73
`
`at 25–26. But Petitioner’s expert testified that Craw’s “generic” interfaces support
`
`many different applications, not just a health-monitoring application. Ex. 1003
`
`¶¶ 75–76. Craw’s interfaces are just as generic as Lee’s Bluetooth® API and do not
`
`constitute an “application-specific interface.”
`
`IV. CONCLUSION
`For the foregoing reasons, Valencell respectfully requests that the Director
`
`reverse the Board’s determination that the challenged claims are unpatentable as
`
`obvious over Luo and Craw, alone or in combination with Wolf.
`
`Dated: December 10, 2021
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Daniel F. Olejko
`Attorney for Patent Owner
`Registration No. 76,958
`Bragalone Olejko Saad PC
`2200 Ross Ave.
`Suite 4600 – West
`Dallas, TX 75201
`
`15
`
`
`
`
`
`Case IPR2017-00319
`U.S. Pat. No. 8,923,941
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned hereby certifies that this document was served via electronic
`
`mail on December 10, 2021, to Petitioner via counsel, James M. Glass, Sam Stake,
`
`and Ogi Zivojnovic at
`
`the email addresses:
`
`jimglass@quinnemanuel.com,
`
`samstake@quinnemanuel.com, ogizivojnovic@quinnemanuel.com, pursuant
`
`to
`
`Petitioner’s consent in its Updated Mandatory Notices at page 1.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Daniel F. Olejko
`Attorney for Patent Owner
`Registration No. 76,958
`Bragalone Olejko Saad PC
`2200 Ross Ave.
`Suite 4600 – West
`Dallas, TX 75201
`
`16
`
`